Liberia

Reimbursed Care Access

Liberia maintains strict national controls on classical psychedelics (psilocybin, MDMA, DMT, mescaline, ibogaine, etc.) under its public‑health/drug statutes, while ketamine (racemic) is widely listed as an essential anesthetic and used in clinical settings. There is no evidence of authorized clinical programs, national reimbursement, or regulatory approvals for prescription psychedelic medicines such as esketamine (Spravato) or licensed psilocybin/MDMA therapy; out‑of‑pocket and donor‑funded care remain the dominant financing mechanisms for health services.